Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep676 | Pituitary: basic and neuroendocrinology | ECE2015

Placental IGF1R–PI3K/Akt pathway and its relationship to idiopathic birth weight alterations

Lazo-de-la-Vega-Monroy Maria-Luisa , Gonzalez-Dominguez Martha I , Daza-Benitez Leonel , Barbosa-Sabanero Gloria

Introduction: Alterations in foetal growth lead to neonatal health risks and favour metabolic diseases during adult life. Therefore, the study of birth weight determination and its modifications is crucial for metabolic diseases prevention. Placental growth is a key factor in foetal growth. It has been suggested that insulin and the IGF system play an important role in foetal growth and placental development and function. Although, insulin and IGFs in the umbilical cord blood ...

ea0070ep379 | Reproductive and Developmental Endocrinology | ECE2020

Semen quality improvement after weight loss by very low-calorie ketogenic dietary: A report of two cases

Renck Alessandra , Afonso Teixeira Thiago , Risso Pariz Juliana , Barbosa Trarbach Ericka , Hallak Jorge , Maria Frade Costa Elaine

Considered as the biggest public health problem, the pandemic growth of obesity is associated to decline of male fertility potential over the last 50 years. Thus far, the effect of weight loss on semen parameters is still controversial and poorly understood. In this study we report the effect of significant weight loss on semen parameters of two obese men with metabolic syndrome. The patients followed to a very low-calorie ketogenic diet (VLCKD) according to a commercial weigh...

ea0022p827 | Thyroid | ECE2010

Cito-histologycal correlations in nodular thyroid pathology

Couto Joana , Lobo Claudia , Barbosa Ana Paula , Martins Raquel , Santos Ana Paula , Monteiro Paula , Amaro Teresina , Torres Isabel

Introduction: Fine needle biopsy (FNB) is a very important diagnostic tool in the assessment of thyroid nodules and plays a prominent role in therapeutic approach. It has a sensitivity around 83 to 85% and a specificity around 80 to 92%.Aims: To correlate cytological (FNB) and final histopathological data in patients with nodular thyroid pathology.Methods: A retrospective study of patients who underwent surgical procedure from Janu...

ea0021p112 | Clinical practice/governance and case reports | SFEBES2009

Somatostatin analogues as an alternative treatment for type 1 gastric endocrine tumour: case report

Santos Ana P , Martins Raquel G , Couto Joana , Barbosa Ana P , Abreu Nuno , Leca Luis , Torres Isabel

Introduction: Gastric endocrine tumors (GET) are rare. Type 1 tumors are non-functioning, almost exclusively benign lesions, usually presenting as multiple polyps, usually <1 cm in diameter, which arise from gastric enterochromaffin-like cells in response to chronically elevated gastrin, secondary to (auto-immune) atrophic fundic gastritis. These tumors were traditionally treated with total gastrectomy, like adenocarcinomas. Currently, surveillance or endoscopic treatment ...

ea0056ep120 | Pituitary and Neuroendocrinology | ECE2018

Macroprolactinoma found in obesity setting: case report

Sofia Osorio Ana , Filipa Martins Ana , Vieira Joao , Barbosa David , Faria Carolina , Nobre Ema , Joao Bugalho Maria

Obesity is growing fast worldwide. Although environmental factors play a major role, endocrine dysfunction may contribute to the weight gain. We report an invasive macroprolactinoma diagnosed in obesity setting. A 35-year-old male was referred to our endocrine outpatient department due to grade 2 obesity (IMC 38.4 Kg/m2). His weight was increasing since the beginning of his professional activity at the age of 20 due to a sedentary lifestyle. On physical examination he had an h...

ea0099ep390 | Adrenal and Cardiovascular Endocrinology | ECE2024

Endocrinopathys in poems syndrome – what’s its clinical implications?

Peixe Carolina , Vicente Rocha Jose , De Grine Severino Mariana , Lopes Marta , Raquel Gomes Ana , Ines Alexandre Maria , Paula Barbosa Ana

Introduction: POEMS syndrome is a rare multisystem disorder characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes. Different endocrinopathies are found in 58-80% of patients, however, its pathophysiology remains unknown. Hypogonadism (primary and secondary) is the most common endocrinopathy (79% of patients), with other abnormalities including hyperprolactinemia (56%), primary hypothyroidism (54%), abnormal glu...

ea0081p741 | Thyroid | ECE2022

Efficacy of radioactive iodine treatment in Graves Disease using a calculated 131I dose and predictive factors of success in a Portuguese cohort

Franco Sara , Teixeira Ferreira Rita , Cardoso Ferreira Ines , Quitalo Ana , Barbosa David , Manuel Costa Maria , Vara Luiz Henrique , Raimundo Luisa , Isabel Santos Ana

Aim: Dose corrected for thyroid gland size is one of the methods used to determine radioactive iodine (RAI) activity for patients with Graves disease (GD). This study was aimed to investigate the real-world success rate of this method and the predictors of success after first treatment.Methods: This is a retrospective study of 80 patients with GD treated between 2014 and 2020 in a tertiary referral hospital in Almada, Portugal. The successful group was d...

ea0090p388 | Endocrine-related Cancer | ECE2023

PRRT 177Lu-DOTA-TATE in pancreatic neuroendocrine tumors – When to initiate?

Franco Sara , Lucena Sampaio Ines , Ferreira Goncalo , Barbosa Daniel , Gil-Santos Sara , Vara Luiz Henrique , Paula Santos Ana , Torres Isabel , Duarte Hugo

Introduction: The best timing for PRRT (peptide receptor radionuclide therapy) in the case of pancreatic neuroendocrine tumors (panNETs) is still to define, as randomized prospective trials are lacking. Recent studies suggest that some systemic therapies can affect response to PRRT, favoring an earlier use of the latter.Objective: To determine the efficacy and toxicity of PRRT, comparing its results when used as a second line systemic therapy (a...

ea0049ep1465 | Thyroid (non-cancer) | ECE2017

Isolated bone metastases: a rare form of presentation of papillary thyroid carcinoma

Peyroteo Mariana , Ribeiro Catia , Martins Pedro C , Ferreira Ana , Giesteira Laurinda , Barbosa Rui , Carvalho Machado , Ramalho Antonio , Moreira Augusto , de Sousa Abreu

Background: Papillary thyroid cancer (PTC) is the most frequent type of well-differentiated thyroid cancer (WDTC) and frequently poses a management dilemma. Its indolent behavior associated with high long term survival support the trend towards a more conservative management approach. The authors present a case of isolated bone metastases as the form of presentation of papillary thyroid carcinoma. A 61-year-old man was admitted with complaints of lower back pain for the previo...

ea0037gp.05.10 | Developmental and paediatric endocrinology | ECE2015

Ghrelin and GHSR1 receptor in placentas of SGA, LGA, and AGA newborns

Gonzalez Dominguez Martha I , de la Vega Monrroy Maria Luisa Lazo , Zaina Silvio , Sabanero Myrna , Daza-Benitez Leonel , Malacara Juan Manuel , Barbosa-Sabanero Gloria

Introduction: Intrauterine growth is a biological process regulated by maternal, placental, and foetal endocrine signals. Birth weight is an indicator of the health of the newborn. Alterations in foetal growth lead to perinatal health risks and favour metabolic diseases during adult life. Therefore, the study of endocrine factors determining birth weight, such as ghrelin is an important issue. Ghrelin may exist as two molecular forms, desacyl ghrelin (DAG) and acyl ghrelin (AG...